Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

Cathie Wood's ARK adds more Tesla stock, sells DraftKings

EditorFrank DeMatteo
Published 04/02/2024, 09:10 PM
Updated 04/02/2024, 09:10 PM
© Reuters.

Cathie Wood's ARK ETFs disclosed their daily trades for Tuesday, April 2nd, 2024, with significant activity in both purchasing and selling across various sectors. The most noteworthy trade of the day was the sale of DraftKings Inc. (NASDAQ:DKNG), with ARK offloading a substantial 481,452 shares from its ARKK and ARKW ETFs, amounting to a total dollar value of $21,636,452.

Another major transaction was the sale of shares in Exact Sciences Corp (NASDAQ:EXAS), with 266,380 shares sold between the ARKK and ARKG ETFs, totaling $18,755,816 in value. These sales could indicate a strategic shift in ARK’s portfolio or a response to market conditions.

On the buying side, Tesla Inc (NASDAQ:TSLA) continued to be a favorite, with ARK purchasing 234,998 shares across three of its ETFs, representing a massive investment of $41,176,349. This move reinforces ARK's bullish stance on Tesla, which has been a recurring trend in recent trades.

Kratos Defense & Security (NASDAQ:KTOS) also saw a notable increase in holdings, with ARK buying 107,711 shares through its ARKQ and ARKX ETFs, valued at $1,977,574. This purchase aligns with ARK's interest in defense and aerospace technologies, sectors that have been receiving increasing attention from the investment community.

ARK also increased its position in Moderna Inc (NASDAQ:MRNA) by acquiring 14,447 shares through its ARKG ETF, totaling $1,525,603. This trade reflects ARK’s ongoing investment in the biotechnology sector, especially in companies at the forefront of innovation and drug development.

Other significant buys included 190,362 shares of Pacific Biosciences (NASDAQ:PACB) of California (NASDAQ:PACB) and 42,007 shares of Pinterest Inc (NYSE:NYSE:PINS), with total dollar values of $694,821 and $1,483,687, respectively. These trades demonstrate ARK's diverse interest in both the health technology and social media spaces.

Personalis Inc (NASDAQ:PSNL) saw a smaller purchase of 23,786 shares, but this follows a pattern of consistent buying in the genomics company, as seen in previous trades, suggesting a growing confidence in its long-term potential.

Overall, Cathie Wood's ARK ETFs continue to make bold moves in the market, with a clear focus on innovation-driven companies. Investors and market watchers alike will be keen to see how these trades play out in the context of ARK's broader investment strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.